EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 30 filers reported holding EVOGENE LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27 | -44.9% | 45,400 | 0.0% | 0.00% | – |
| Q2 2023 | $49 | -33.8% | 45,400 | -61.6% | 0.00% | – |
| Q1 2023 | $74 | +17.5% | 118,193 | +31.8% | 0.00% | – |
| Q4 2022 | $63 | -99.9% | 89,700 | -4.5% | 0.00% | – |
| Q3 2022 | $78,000 | -60.8% | 93,918 | -63.7% | 0.00% | – |
| Q2 2022 | $199,000 | -66.7% | 258,604 | -43.7% | 0.00% | -100.0% |
| Q1 2022 | $597,000 | +20.4% | 459,081 | +51.8% | 0.00% | 0.0% |
| Q4 2021 | $496,000 | -29.1% | 302,365 | +14.0% | 0.00% | 0.0% |
| Q3 2021 | $700,000 | +113.4% | 265,200 | +176.8% | 0.00% | – |
| Q2 2021 | $328,000 | +224.8% | 95,800 | +277.2% | 0.00% | – |
| Q3 2020 | $101,000 | – | 25,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |